Sign Up Today and Learn More About Oxford Endovascular Stock
Invest in or calculate the value of your shares in Oxford Endovascular or other pre-IPO companies through EquityZen's platform.
Oxford Endovascular Stock (OXEN)
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
About Oxford Endovascular Stock
Founded
2015
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Oxford Endovascular Press Mentions
Stay in the know about the latest news on Oxford Endovascular
Oxford Endovascular secures £8 million to take novel brain aneurysm tech to human trials
med-technews • Jun 26, 2024
Oxford Endovascular, an origami-inspired startup raises £8M to fight brain aneurysms — TFN
techfundingnews • Jun 26, 2024
Oxford Endovascular Closes GBP8M Series A+ Funding
finsmes • Jun 26, 2024
Origami-engineered device ‘could prevent brain haemorrhage’
businesscloud • Apr 10, 2021
Oxford Endovascular raises $10m for device to prevent brain haemorrhage
angelnews • Apr 09, 2021
Oxford Endovascular Management
Leadership team at Oxford Endovascular
Clinical Director
James Byrne
CEO and Co-founder
Mike Karim
Join now and verify your accreditation status to gain access to:
- Oxford Endovascular Current Valuation
- Oxford Endovascular Stock Price
- Oxford Endovascular Management
- Available deals in Oxford Endovascular and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Oxford Endovascular Cap Table and Funding History by Share Class and Liquidity Preferences
- Oxford Endovascular Revenue and Financials
- Oxford Endovascular Highlights
- Oxford Endovascular Business Model
- Oxford Endovascular Risk Factors
- Oxford Endovascular Research Report from SACRA Research
Trading Oxford Endovascular Stock
How to invest in Oxford Endovascular stock?
Accredited investors can buy pre-IPO stock in companies like Oxford Endovascular through EquityZen funds. These investments are made available by existing Oxford Endovascular shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Oxford Endovascular stock?
Shareholders can sell their Oxford Endovascular stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
